Archive for the ‘Lyme’ Category

Lyme Disease: Medical Myopia & the Hidden Global Pandemic

Lyme Disease: Medical Myopia & The Hidden Global Pandemic

A Patient’s Guide to Navigating the Labyrinth of Diagnosis and Treatment

Coming out on August 30, 2019

51qYZzBhxjL._SX316_BO1,204,203,200_

What if, at this very moment, hundreds of thousands of people were unaware that they were living in midst of an epidemic so large that it dwarfs the AIDS epidemic by sheer numbers in North America?

What if this epidemic cut across all populations: women and men, children and adults, the infirm and the fit, the very poor and the very rich?

And what if many of our best doctors in cities like New York, London, Paris, Dublin, Sydney and San Francisco were unaware of this very same problem?

This epidemic is upon us. It lurks in the most seductive of locations outside our cities – sought after vacation places frequented by urban dwellers. These are the favorite getaway spots for the often millions of people who work in our city centers, many of whom are unaware that they are at risk of infection from this insidious microbe.

The epidemic in question is a tick-borne disease, namely the spirochete bacterium Borrelia burdorferi, or Lyme disease, as it is more commonly known. Along with a number of other co-infection pathogens, including deadly viruses, this bacterium has become the scourge of the Northern Hemisphere and is now spreading into Asia and even Australia.

In this book, Dr. Bernard Raxlen attempts to answer many of those questions through the perspectives of patients and physicians from around the world, exploring the reasons for the medical myopia that blocks accurate diagnosis and treatment of tick-borne disease. He draws on his thirty years in the field and more than forty thousand clinical hours listening to and treating TBD patients and also invites other expert physicians in TBD from around the world to share their experiences and expertise. His recovered former patient, co-collaborator and Lyme advocate, Allie Cashel, author of Suffering the Silence: Chronic Lyme Disease in an Age of Denial, contributes a section of the book, illuminating life after TBD and the difficulties encountered in the post-Lyme world.

Also includes contributions from international authorities Dr. Laura Alonso Canal (Spain), Dr. Jennifer Armstrong (Canada), Michael Cook (UK), Doug Fearn (US), Dr. John Lambert (Ireland), Jenna Luché-Thayer (United Nations), Dr. Mualla McManus (Australia), Zhaneta Misho (Germany), Dr. Omar Morales (Mexico), Dr. Christian Perrone (France), Dr. Armin Schwarzbach (Germany), and Dr. Leo Shea (US); with illustrations by Rolo Ledesma.

Coming out August 30, 2019.  To preorder:  https://www.amazon.com/Lyme-Disease-Medical-Myopia-Epidemic/dp/1781611300

__________________

For a great paper titled “Double Rejection of the TBD Patient With Psychiatric Symptoms,” written by Dr. Raxlen: Raxlen’s paper on TBD’s

Favorite quote:

An untreated or partially treated Lyme patient is reminiscent of a disoriented train traveler in a Kafka-like scenario. The traveler wishes to board a train on the East Coast with the intention of reaching the West Coast. However, once arrived at the train station, the traveler can’t find the “right boarding track.” The information given to him concerning “schedules and time” is hopelessly “outdated” and inaccurate. In addition, the “information booth” official continues to direct him to the wrong gate. The conductor on the platform denies the existence of such a train ever traveling to the West Coast. The traveler, hopelessly confused, finally boards the correct train that appears to head to the West Coast. Halfway through the journey, he is told that his destination has been reached. He is instructed to get off the train. Little wonder, the “traveler” is disoriented, feels crazy, and begins to doubt the reality of his/her own senses. After all, if the supposed successful course of treatment does not improve, the patient’s symptoms are no better off at the end than he was at the beginning. – Dr. Raxlen

IDSA’s Insincere Request For Guidelines Feedback

https://www.lymedisease.org/idsa-insincere-request/

19 JUL 2019
By Dorothy Kupcha Leland  Touched by Lyme

Last month, the IDSA released a long-awaited draft of its latest Lyme treatment guidelines. The accompanying announcement stated: “We are looking for feedback from not only physicians and healthcare professionals, but also individuals affected by Lyme disease, such as patients, care givers, patient organization members, advocates, and researchers.”

Maybe you thought you’d print off the 100-page report and curl up on the couch to read it? Ain’t gonna happen.
How about downloading a PDF and reading it on your Kindle? Heck no.

Why not, you ask? Because the IDSA has purposely made it impossible for anybody to make a copy of either the guidelines or the 200-page list of accompanying resources.

The only way to read any of it is to go to the IDSA website and view it in real time on your screen.

Makes you wonder how serious that request for public feedback actually is, doesn’t it? This cumbersome process makes it difficult for anybody to read such long documents—whether you are a patient, a busy doctor, or a journalist interested in the story.

Wait. We’re not done yet. After you’ve slogged through all that just to read the darn thing, there’s another burdensome procedure for making comments.

Here’s how the IDSA website explains it:

In this form, you are given 20 opportunities to enter your comments on the guideline. Please note that you will need to complete your review in one sitting as your work in progress cannot be saved. Once you hit the “Save and Next” button at the end, your responses will be recorded and saved. If at the end you have additional comments, please click “Enter Additional Comments” and complete the survey again.

For each comment, you must select which section of the guideline your comment relates to:

·       General comments on entire draft

·       Introduction & methods

·       Tick bites prevention and prophylaxis of Lyme disease

·       Early localized Lyme disease (erythema migrans)

·       Neurologic Lyme disease

·       Lyme carditis

·       Lyme arthritis

·       Prolonged symptoms following treatment of Lyme disease

·       Cutaneous manifestations of Eurasian Lyme disease

·       Lyme disease coinfections

·       Supplement Materials

For each comment, you must be specific (section, page number, line and/or table number, comment).

Any questions marked with an asterisk (*) require an answer in order to progress through the comment form.

You must click “Save and Next” at the bottom of each page or your responses will not be saved.

Complicated enough for you?

LymeDisease.org is currently going over the draft guidelines with a fine-tooth comb and will have comments ready soon. Stay tuned.

Aside from the content of the document itself—which, spoiler alert! is plenty disturbing—the process by which the IDSA arrived at this draft is highly problematic.

Why the guidelines matter

For those who may be new to this party, some background:

The 2006 IDSA Lyme guidelines have long been a point of contention. They rigidly define what is “allowed” to be diagnosed as Lyme disease and limit permissible treatment to a short course of antibiotics. Thus, they deny treatment to the unlucky many who don’t fall within those narrow parameters.

Furthermore, insurance companies often use the guidelines to deny payment for Lyme treatment, and medical boards use them to revoke licenses of physicians who don’t follow them. Currently, the guidelines are also the centerpiece of a federal lawsuit. It charges that the document’s authors and eight insurance companies conspired to deny medical care to Lyme disease patients.

In 2016, the IDSA announced that it would re-evaluate and update the Lyme guidelines. At the time, the group also announced with much fanfare that they had named a “patient representative” on the guidelines panel. When our organization spoke to her, the woman in question admitted that she had no experience with Lyme disease whatsoever!

After the Lyme community protested loudly, the IDSA changed her designation from “patient representative” to “consumer representative.” They also said they would add three “patients” to the panel as well. But “to protect their privacy,” the IDSA refused to name the people who were supposedly there to “represent” us.

So basically, three people we’ve never heard of—and never will hear of—supposedly spoke on behalf of the Lyme community throughout the guidelines process. Are you feeling “represented” yet?

Click here for the draft guidelines.

______________________________

For more:  https://madisonarealymesupportgroup.com/2019/07/09/idsa-lyme-disease-treatment-management-business-as-usual-leaves-those-with-persisting-symptoms-to-suffer-die/

https://madisonarealymesupportgroup.com/2019/06/27/idsa-aan-acr-2109-draft-lyme-guidelines-public-comments-allowed-until-aug-10-2019/

https://madisonarealymesupportgroup.com/2017/06/29/british-lord-says-cdcidsa-lyme-guidelines-not-fit-for-purpose/

https://madisonarealymesupportgroup.com/2017/08/19/dr-liegner-guidelines-used-by-managed-care-causing-lyme-deaths/

 

Did Pentagon Turn Ticks into Bioweapons That Spread Lyme Disease? N.J. Congressman Wants Answers

Did Pentagon turn ticks into bioweapons that spread Lyme Disease? N.J. congressman wants answers.

Rep. Chris Smith speaks in Middletown at a 9/11 memorial ceremony. ( Tom Haydon | NJ Advance Media for NJ.com)

Tom Haydon | NJ Advance Media

Rep. Chris Smith speaks in Middletown at a 9/11 memorial ceremony. ( Tom Haydon | NJ Advance Media for NJ.com)

WASHINGTON

It sounds like the plot for a science fiction movie: A government agency decides to use ticks and other insects to spread disease and kill its enemies, only the ticks got out and infected the country’s residents itself.

New Jersey Rep. Chris Smith says that may not be too far-fetched.

He’s won approval from the House to have the Defense Department’s inspector general investigate whether the Pentagon actually looked at using ticks stuffed with pathogens as bioweapons during the height of the Cold War beginning in the 1950s.

He said several books and articles pinned the blame on the Pentagon, and perhaps some of the ticks and insects got out and helped to spread illnesses, most notably Lyme disease.

“If this isn’t true, let’s put it to rest,” said Smith, R-4th Dist. “For the sake of public health we should demand these answers.”

The provision is part of the National Defense Authorization Act, which sets defense policy for the 12 months beginning Oct. 1. That’s the same bill that includes Pentagon projects at Joint Base McGuire-Dix-Lakehurst and the Picatinny Arsenal, as well as prevents President Donald Trump from launching an attack on Iran without first receiving congressional approval.

House Democrats allowed Smith to bring up an amendment to begin the study, and then joined with Republicans in unanimously adding it to the legislation.

“With Lyme disease and other tick-borne diseases exploding in the United States — with an estimated 300,000 to 437,000 new cases diagnosed each year and 10-20 percent of all patients suffering from chronic Lyme disease — Americans have a right to know whether any of this is true,” Smith said. “And have these experiments caused Lyme disease and other tick-borne disease to mutate and to spread?”

Since a similar provision is not in the Senate version of the bill, it will be up to congressional negotiators to make sure it makes the final defense legislation. Smith said he’s talking to Senate leaders to gain their ascent.

The Lyme Disease Association is pushing senators to agree to the study.

“We know that the government was doing other kinds of experiments during that time,” said Pat Smith, president of the Jackson, N.J.-based group. “Absolutely it needs to be looked at. The public needs to know if this has occurred.”

And if it turns to be true?

“Maybe there is something in the research that would lead to helping patients get better or constrain the spread of ticks across the country,” Smith said.

Newby Responds to Washington Post’s Slam About Bitten

https://www.lymedisease.org/newby-responds-wapo/

Newby responds to Washington Post’s slam about BITTEN

 

 

 

Human Seroprevalence of Tick-Borne Anaplasma, Lyme, and Rickettsia Species in Northern California

https://www.ncbi.nlm.nih.gov/pubmed/31295054/

2019 Jul 11. doi: 10.1089/vbz.2019.2489. [Epub ahead of print]

Human Seroprevalence of Tick-Borne Anaplasma phagocytophilum, Borrelia burgdorferi, and Rickettsia Species in Northern California.

Abstract

There is a paucity of data on human exposure to tick-borne pathogens in the western United States. This study reports prevalence of antibodies against three clinically important tick-borne pathogens (Borrelia burgdorferi, Anaplasma phagocytophilum, and Rickettsia spp.) among 249 people in five counties in northern California. Individuals from Humboldt County were recruited and answered a questionnaire to assess risk of exposure to tick-borne pathogens. Samples from other counties were obtained from a blood bank and were anonymized. Seventeen (6.8%) samples were seropositive for antibodies against at least one pathogen: five for A. phagocytophilum, eight for B. burgdorferi, and four for Rickettsia spp. Women and people aged 26-35 had higher seroprevalence compared to other demographic groups. Santa Cruz County had no seropositive individuals, northern Central Valley counties had three seropositive individuals (all against A. phagocytophilum), and Humboldt County had 14 (all three pathogens), a significant, four-fold elevated risk of exposure. The Humboldt County questionnaire revealed that a bird feeder in the yard was statistically associated with exposure to ticks, and lifetime number of tick bites was associated with increasing age, time watching wildlife, and time hiking. Three-quarters of respondents were concerned about tick-associated disease, 81.0% reported experiencing tick bites, and 39.0% of those bitten reported a tick-borne disease symptom, including skin lesions (76.4%), muscle aches (49.1%), joint pain (25.5%), or fever (23.6%).

Despite high levels of concern, many individuals who had been bitten by a tick were not tested for a tick-borne pathogen, including those with consistent symptoms.

We highlight the need for further research and dissemination of information to residents and physicians in Northern California regarding tick-associated disease, so that appropriate medical attention can be rapidly sought and administered.

________________

**Comment**

Again, the numbers are going to be much higher as they used the abysmal serology testing which tests for antibodies – not the organisms.

More on California:  https://madisonarealymesupportgroup.com/2018/05/24/lyme-in-california-what-you-need-to-know/

https://madisonarealymesupportgroup.com/2018/05/19/infected-ticks-in-california-its-complicated/

https://madisonarealymesupportgroup.com/2017/08/07/california-lyme-cases-get-no-respect/

https://madisonarealymesupportgroup.com/2018/06/23/say-what-california-fifth-in-nation-for-lyme-insurance-claims/

https://madisonarealymesupportgroup.com/2018/02/02/miyamotoi-in-ixodes-pacificus-in-california/

https://madisonarealymesupportgroup.com/2018/02/15/b-miyamotoi-in-ca-ticks-for-a-long-time/

https://madisonarealymesupportgroup.com/2018/02/14/borrelia-miyamotoi-in-ca-serodiagnosis-is-complicated-by-multiple-endemic-borrelia-species/

https://madisonarealymesupportgroup.com/2017/10/09/bb-in-california-chipmunk-and-squirrels/

https://madisonarealymesupportgroup.com/2019/05/26/educating-california-about-lyme-disease/